Contracepción sólo con gestágenos - Sociedad Española de ...
Contracepción sólo con gestágenos - Sociedad Española de ...
Contracepción sólo con gestágenos - Sociedad Española de ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
270<br />
SOCIEDAD ESPAÑOLA DE CONTRACEPCIÓN<br />
Referencias<br />
Affandi B, Korver T, Geurts TB, Coelingh Bennink HJ. A pilot efficacy study with a single-rod <strong>con</strong>traceptive implant (Implanon) in 200<br />
Indonesian women treated for ‹ or = 4 years. Contraception 59(3), 167-174. 1999.<br />
Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception 1998;58:99S-107S.<br />
American College of Obstetricians and Gynecologists. Breastfeeding. Maternal and Infant Aspects. ACOG educational bulletin 258.<br />
Washington, DC, July 2000. Int J Gynecol Obstet 2001; 74:217-233. (Nivel III).<br />
American College of Obstetrics and Gynecologists. Hormonal <strong>con</strong>traception. ACOG Technical Bulletin 198. Washington, DC: ACOG,<br />
1994. (Nivel III).<br />
Baheiraei A, Ardsetani N, Ghaziza<strong>de</strong>h Sh. Effects of progestogen-only <strong>con</strong>traceptives on breast-feeding and infant growth. Int J Gynecol<br />
Obstet 2001; 74:203-205. (Nivel III).<br />
Barkfeldt J, Virkkunen A, Dieben TOM. The effects of two progestogen-only pills <strong>con</strong>taining either <strong>de</strong>sogestrel (75 micrograms per<br />
day) or levonorgestrel (30 microgrammes per day) on lipid metabolism. Contraception 2001;64:295-299.<br />
Beerthuizen R, van Beek A, Massai R, Mäkäräinen L, in’t Hout J, Coeling Bennink H. Bone mineral <strong>de</strong>nsity during long-term use of<br />
the progestagen <strong>con</strong>traceptive implant ImplanonÒ compared to non-hormonal method of <strong>con</strong>traception. Hum Reprod 2000; 15,1:<br />
118-122. (nivel II-2)<br />
Bennink HJ. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonorgestrel <strong>con</strong>traceptive implant. Eur J<br />
Contracept Reprod Health Care 2000;5:12-20.<br />
Bjarnadottir,RI, Gottfredsdottir, H, Sigurdardottir, K, Geirsson, RT, Dieben, TO. Comparative study of the effects of a progestogenonly<br />
pill <strong>con</strong>taining <strong>de</strong>sogestrel and an intrauterine <strong>con</strong>traceptive <strong>de</strong>vice in lactating women. Br J Obstet Gynaecol 2001; 108: 1174-<br />
1180<br />
Booranabunyat S, Taneepanichskul S. Implanon use in Thai women above the age of 35 years. 2004<br />
Branks E, Berrington A, Casabonne D. Overview of the relationship between use of progestogen-only <strong>con</strong>traceptives and bone mineral<br />
<strong>de</strong>nsity. Br J Obstet Gynaecol 2001, 108:1214-1221. (Nivel III).<br />
British National Formulary volume 44 September 2003. www.BNF.org<br />
British National Formulary. BNF 49. 2005. www.bnf.org.uk<br />
Broome M, Fotherby K. Clinical experience with the progestogen-only pill. Contraception 1990;42:489–95.<br />
Bumenthal PD, Gaffikub J, Affandi B et al. Training for Norplant implant removal: assessment of learning curves and competency.<br />
Obstetrics and Gynaecology. 1997: 89:2;174-8<br />
Campbell OM, Gray RH. Characteristics and <strong>de</strong>terminants of postpartum ovarian function in women in the United States. Am J Obstet<br />
Gynecol 1993; 169:55-60 (Nivel II-2).<br />
Chilvers CE. Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge. Drug Safety 1996; 15:212-2128.<br />
(Nivel III).<br />
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal <strong>con</strong>traceptives: collaborative reanalysis of<br />
individual data on 53 297 women with breast caner and 100 239 women without breast cancer form 54 epi<strong>de</strong>miological studies.<br />
Lancet 1996;347:1713-27.<br />
Collaborative Study Group on the Desogestrel-Containing Progestogen-only Pill. A double-blind study comparing the <strong>con</strong>traceptive<br />
efficacy, acceptability and safety of two progestogen-only pills <strong>con</strong>taining <strong>de</strong>sogestrel 75 mg/day or levonorgestrel 30mg/day. Eur<br />
J Contracept Reproduct Health Care 1998; 3:169-178.<br />
Cromer B, Blair J, Mahan J, Zibners L, Naumovski Z. A prospective comparision of bone <strong>de</strong>nsity in adolescent girls receiving <strong>de</strong>pot<br />
medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral <strong>con</strong>traceptives. J Pediatr 1996; 129:671-676.<br />
Crowther NR, Holbrook AM, Kenwright R, Kenwright M. Drug Interactions among commonly used medications. Canadian Family<br />
Physician 1997;43:1972-81.<br />
Croxatto HB, Mäkäräinen L. The Pharmacodynamics and Efficacy of Implanon. An Overview of the Data. Contraception 1998; 58:91S-<br />
97S.<br />
Croxatto HB, Urbancsek J, Massai R, Coelingh Bennik H, van Beek A. A multicentre efficacy and safety study of a single <strong>con</strong>traceptive<br />
implant, Implanon Study Group. Human Reproduction 1999;14:976-81.
Change language